APA (7th ed.) Citation

Fautrel, B., Smolen, J. S., Benedetti, F., Caporali, R., Doerner, T., Pieper, B., & Jang, M. Treatment journey in rheumatoid arthritis with biosimilars: From better access to good disease control through cost savings and prevention of nocebo effects. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Fautrel, Bruno, Josef S. Smolen, Fabrizio Benedetti, Roberto Caporali, Thomas Doerner, Burkhard Pieper, and Minjun Jang. Treatment Journey in Rheumatoid Arthritis with Biosimilars: From Better Access to Good Disease Control Through Cost Savings and Prevention of Nocebo Effects. BMJ Publishing Group.

MLA (9th ed.) Citation

Fautrel, Bruno, et al. Treatment Journey in Rheumatoid Arthritis with Biosimilars: From Better Access to Good Disease Control Through Cost Savings and Prevention of Nocebo Effects. BMJ Publishing Group.